Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
However, it may cover Spravato, which contains esketamine. This is an FDA-approved drug that derives from ketamine and can help manage treatment-resistant depression. Despite not yet having FDA ...
Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.
Ketamine has long been seen as a potential ... who have cycled through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster for Janssen, which ...
We can help. Stella Mental Health in Encinitas specializes in Spravato (esketamine) nasal spray, ketamine infusion therapy, stellate ganglion blocks (SGB) and integration therapy. Schedule an ...
A prescription version of ketamine called esketamine (Spravato) was approved in 2019 by the FDA for treatment-resistant depression. Guidelines require its use “under the supervision of a health care ...
The safety of repeated ketamine therapy, particularly for long-term use, requires further investigation. The Role of Esketamine in the Treatment of Depression Esketamine, the S-enantiomer of ketamine, ...
Ketamine is an injectable anesthetic (a medicine that puts people to sleep during surgical procedures). Ketamine is related to the recreational drug phencyclidine (PCP). Studies have found that low ...
China: A recent randomized clinical trial has highlighted the potential benefits of intraoperative esketamine in reducing postpartum depression (PPD) among women undergoing cesarean delivery. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results